Alzheimer's Disease Diagnostic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

The global market for Alzheimer's Disease Diagnostic was estimated to be worth US$ 3618 million in 2023 and is forecast to a readjusted size of US$ 4024.3 million by 2030 with a CAGR of 1.5% during the forecast period 2024-2030

Alzheimer's Disease Diagnostic Market Size

M= millions and B=billions

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Diagnostic, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Alzheimer's Disease Diagnostic by region & country, by Type, and by Application.

The Alzheimer's Disease Diagnostic market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Diagnostic.

Market Segmentation

• Report Metric

• Details

• Report Title

• Alzheimer's Disease Diagnostic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Forecasted Market Size in 2030

• US$ 4024.3 million

• CAGR(2024-2030)

• 1.5%

• Market Size Available for Years

• 2019-2030

• Global Alzheimer's Disease Diagnostic Companies Covered

• Eli Lilly, TauRx, Alector, Accera, Treventis, Neuro-Bio, Cognition Therapeutics

• Global Alzheimer's Disease Diagnostic Market, by Region

• North America (U.S., Canada, Mexico)

  Europe (Germany, France, UK, Italy, etc.)

  Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

  South America (Brazil, etc.)

  Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

• Global Alzheimer's Disease Diagnostic Market, Segment by Type

• Genetic Testing

  Neurological Exam

  Mini-Mental State Exam(MMSE)

  Brain Imaging

  Other

• Global Alzheimer's Disease Diagnostic Market, Segment by Application

• Clinics

  Hospitals

  Diagnostic Centers

  Other

• Forecast Units

• USD million in value

• Report Coverage

• Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Alzheimer's Disease Diagnostic manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Alzheimer's Disease Diagnostic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Alzheimer's Disease Diagnostic in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Alzheimer's Disease Diagnostic Product Introduction
    1.2 Global Alzheimer's Disease Diagnostic Market Size Forecast
    1.3 Alzheimer's Disease Diagnostic Market Trends & Drivers
        1.3.1 Alzheimer's Disease Diagnostic Industry Trends
        1.3.2 Alzheimer's Disease Diagnostic Market Drivers & Opportunity
        1.3.3 Alzheimer's Disease Diagnostic Market Challenges
        1.3.4 Alzheimer's Disease Diagnostic Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Alzheimer's Disease Diagnostic Players Revenue Ranking (2023)
    2.2 Global Alzheimer's Disease Diagnostic Revenue by Company (2019-2024)
    2.3 Key Companies Alzheimer's Disease Diagnostic Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Alzheimer's Disease Diagnostic Product Offered
    2.5 Key Companies Time to Begin Mass Production of Alzheimer's Disease Diagnostic
    2.6 Alzheimer's Disease Diagnostic Market Competitive Analysis
        2.6.1 Alzheimer's Disease Diagnostic Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Alzheimer's Disease Diagnostic Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Diagnostic as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Genetic Testing
        3.1.2 Neurological Exam
        3.1.3 Mini-Mental State Exam(MMSE)
        3.1.4 Brain Imaging
        3.1.5 Other
    3.2 Global Alzheimer's Disease Diagnostic Sales Value by Type
        3.2.1 Global Alzheimer's Disease Diagnostic Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Alzheimer's Disease Diagnostic Sales Value, by Type (2019-2030)
        3.2.3 Global Alzheimer's Disease Diagnostic Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Clinics
        4.1.2 Hospitals
        4.1.3 Diagnostic Centers
        4.1.4 Other
    4.2 Global Alzheimer's Disease Diagnostic Sales Value by Application
        4.2.1 Global Alzheimer's Disease Diagnostic Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Alzheimer's Disease Diagnostic Sales Value, by Application (2019-2030)
        4.2.3 Global Alzheimer's Disease Diagnostic Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Alzheimer's Disease Diagnostic Sales Value by Region
        5.1.1 Global Alzheimer's Disease Diagnostic Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Alzheimer's Disease Diagnostic Sales Value by Region (2019-2024)
        5.1.3 Global Alzheimer's Disease Diagnostic Sales Value by Region (2025-2030)
        5.1.4 Global Alzheimer's Disease Diagnostic Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Alzheimer's Disease Diagnostic Sales Value, 2019-2030
        5.2.2 North America Alzheimer's Disease Diagnostic Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Alzheimer's Disease Diagnostic Sales Value, 2019-2030
        5.3.2 Europe Alzheimer's Disease Diagnostic Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Alzheimer's Disease Diagnostic Sales Value, 2019-2030
        5.4.2 Asia Pacific Alzheimer's Disease Diagnostic Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Alzheimer's Disease Diagnostic Sales Value, 2019-2030
        5.5.2 South America Alzheimer's Disease Diagnostic Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Alzheimer's Disease Diagnostic Sales Value, 2019-2030
        5.6.2 Middle East & Africa Alzheimer's Disease Diagnostic Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Alzheimer's Disease Diagnostic Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Alzheimer's Disease Diagnostic Sales Value
    6.3 United States
        6.3.1 United States Alzheimer's Disease Diagnostic Sales Value, 2019-2030
        6.3.2 United States Alzheimer's Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Alzheimer's Disease Diagnostic Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Alzheimer's Disease Diagnostic Sales Value, 2019-2030
        6.4.2 Europe Alzheimer's Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Alzheimer's Disease Diagnostic Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Alzheimer's Disease Diagnostic Sales Value, 2019-2030
        6.5.2 China Alzheimer's Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Alzheimer's Disease Diagnostic Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Alzheimer's Disease Diagnostic Sales Value, 2019-2030
        6.6.2 Japan Alzheimer's Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Alzheimer's Disease Diagnostic Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Alzheimer's Disease Diagnostic Sales Value, 2019-2030
        6.7.2 South Korea Alzheimer's Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Alzheimer's Disease Diagnostic Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Alzheimer's Disease Diagnostic Sales Value, 2019-2030
        6.8.2 Southeast Asia Alzheimer's Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Alzheimer's Disease Diagnostic Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Alzheimer's Disease Diagnostic Sales Value, 2019-2030
        6.9.2 India Alzheimer's Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Alzheimer's Disease Diagnostic Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Eli Lilly
        7.1.1 Eli Lilly Profile
        7.1.2 Eli Lilly Main Business
        7.1.3 Eli Lilly Alzheimer's Disease Diagnostic Products, Services and Solutions
        7.1.4 Eli Lilly Alzheimer's Disease Diagnostic Revenue (US$ Million) & (2019-2024)
        7.1.5 Eli Lilly Recent Developments
    7.2 TauRx
        7.2.1 TauRx Profile
        7.2.2 TauRx Main Business
        7.2.3 TauRx Alzheimer's Disease Diagnostic Products, Services and Solutions
        7.2.4 TauRx Alzheimer's Disease Diagnostic Revenue (US$ Million) & (2019-2024)
        7.2.5 TauRx Recent Developments
    7.3 Alector
        7.3.1 Alector Profile
        7.3.2 Alector Main Business
        7.3.3 Alector Alzheimer's Disease Diagnostic Products, Services and Solutions
        7.3.4 Alector Alzheimer's Disease Diagnostic Revenue (US$ Million) & (2019-2024)
        7.3.5 Accera Recent Developments
    7.4 Accera
        7.4.1 Accera Profile
        7.4.2 Accera Main Business
        7.4.3 Accera Alzheimer's Disease Diagnostic Products, Services and Solutions
        7.4.4 Accera Alzheimer's Disease Diagnostic Revenue (US$ Million) & (2019-2024)
        7.4.5 Accera Recent Developments
    7.5 Treventis
        7.5.1 Treventis Profile
        7.5.2 Treventis Main Business
        7.5.3 Treventis Alzheimer's Disease Diagnostic Products, Services and Solutions
        7.5.4 Treventis Alzheimer's Disease Diagnostic Revenue (US$ Million) & (2019-2024)
        7.5.5 Treventis Recent Developments
    7.6 Neuro-Bio
        7.6.1 Neuro-Bio Profile
        7.6.2 Neuro-Bio Main Business
        7.6.3 Neuro-Bio Alzheimer's Disease Diagnostic Products, Services and Solutions
        7.6.4 Neuro-Bio Alzheimer's Disease Diagnostic Revenue (US$ Million) & (2019-2024)
        7.6.5 Neuro-Bio Recent Developments
    7.7 Cognition Therapeutics
        7.7.1 Cognition Therapeutics Profile
        7.7.2 Cognition Therapeutics Main Business
        7.7.3 Cognition Therapeutics Alzheimer's Disease Diagnostic Products, Services and Solutions
        7.7.4 Cognition Therapeutics Alzheimer's Disease Diagnostic Revenue (US$ Million) & (2019-2024)
        7.7.5 Cognition Therapeutics Recent Developments

 8 Industry Chain Analysis
    8.1 Alzheimer's Disease Diagnostic Industrial Chain
    8.2 Alzheimer's Disease Diagnostic Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Alzheimer's Disease Diagnostic Sales Model
        8.5.2 Sales Channel
        8.5.3 Alzheimer's Disease Diagnostic Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Alzheimer's Disease Diagnostic Market Trends
    Table 2. Alzheimer's Disease Diagnostic Market Drivers & Opportunity
    Table 3. Alzheimer's Disease Diagnostic Market Challenges
    Table 4. Alzheimer's Disease Diagnostic Market Restraints
    Table 5. Global Alzheimer's Disease Diagnostic Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Alzheimer's Disease Diagnostic Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Alzheimer's Disease Diagnostic Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Alzheimer's Disease Diagnostic Product Type
    Table 9. Key Companies Time to Begin Mass Production of Alzheimer's Disease Diagnostic
    Table 10. Global Alzheimer's Disease Diagnostic Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Diagnostic as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Alzheimer's Disease Diagnostic Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Alzheimer's Disease Diagnostic Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Alzheimer's Disease Diagnostic Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Alzheimer's Disease Diagnostic Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Alzheimer's Disease Diagnostic Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Alzheimer's Disease Diagnostic Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Alzheimer's Disease Diagnostic Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Alzheimer's Disease Diagnostic Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Alzheimer's Disease Diagnostic Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Alzheimer's Disease Diagnostic Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Alzheimer's Disease Diagnostic Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Alzheimer's Disease Diagnostic Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Alzheimer's Disease Diagnostic Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Alzheimer's Disease Diagnostic Sales Value by Region (2019-2024) & (%)
    Table 27. Global Alzheimer's Disease Diagnostic Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Alzheimer's Disease Diagnostic Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Alzheimer's Disease Diagnostic Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Alzheimer's Disease Diagnostic Sales Value, (2025-2030) & (US$ Million)
    Table 31. Eli Lilly Basic Information List
    Table 32. Eli Lilly Description and Business Overview
    Table 33. Eli Lilly Alzheimer's Disease Diagnostic Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Alzheimer's Disease Diagnostic Business of Eli Lilly (2019-2024)
    Table 35. Eli Lilly Recent Developments
    Table 36. TauRx Basic Information List
    Table 37. TauRx Description and Business Overview
    Table 38. TauRx Alzheimer's Disease Diagnostic Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Alzheimer's Disease Diagnostic Business of TauRx (2019-2024)
    Table 40. TauRx Recent Developments
    Table 41. Alector Basic Information List
    Table 42. Alector Description and Business Overview
    Table 43. Alector Alzheimer's Disease Diagnostic Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Alzheimer's Disease Diagnostic Business of Alector (2019-2024)
    Table 45. Alector Recent Developments
    Table 46. Accera Basic Information List
    Table 47. Accera Description and Business Overview
    Table 48. Accera Alzheimer's Disease Diagnostic Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Alzheimer's Disease Diagnostic Business of Accera (2019-2024)
    Table 50. Accera Recent Developments
    Table 51. Treventis Basic Information List
    Table 52. Treventis Description and Business Overview
    Table 53. Treventis Alzheimer's Disease Diagnostic Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Alzheimer's Disease Diagnostic Business of Treventis (2019-2024)
    Table 55. Treventis Recent Developments
    Table 56. Neuro-Bio Basic Information List
    Table 57. Neuro-Bio Description and Business Overview
    Table 58. Neuro-Bio Alzheimer's Disease Diagnostic Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Alzheimer's Disease Diagnostic Business of Neuro-Bio (2019-2024)
    Table 60. Neuro-Bio Recent Developments
    Table 61. Cognition Therapeutics Basic Information List
    Table 62. Cognition Therapeutics Description and Business Overview
    Table 63. Cognition Therapeutics Alzheimer's Disease Diagnostic Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Alzheimer's Disease Diagnostic Business of Cognition Therapeutics (2019-2024)
    Table 65. Cognition Therapeutics Recent Developments
    Table 66. Key Raw Materials Lists
    Table 67. Raw Materials Key Suppliers Lists
    Table 68. Alzheimer's Disease Diagnostic Downstream Customers
    Table 69. Alzheimer's Disease Diagnostic Distributors List
    Table 70. Research Programs/Design for This Report
    Table 71. Key Data Information from Secondary Sources
    Table 72. Key Data Information from Primary Sources
    Table 73. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Alzheimer's Disease Diagnostic Product Picture
    Figure 2. Global Alzheimer's Disease Diagnostic Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Alzheimer's Disease Diagnostic Sales Value (2019-2030) & (US$ Million)
    Figure 4. Alzheimer's Disease Diagnostic Report Years Considered
    Figure 5. Global Alzheimer's Disease Diagnostic Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Alzheimer's Disease Diagnostic Revenue in 2023
    Figure 7. Alzheimer's Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Genetic Testing Picture
    Figure 9. Neurological Exam Picture
    Figure 10. Mini-Mental State Exam(MMSE) Picture
    Figure 11. Brain Imaging Picture
    Figure 12. Other Picture
    Figure 13. Global Alzheimer's Disease Diagnostic Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Alzheimer's Disease Diagnostic Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Product Picture of Clinics
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of Diagnostic Centers
    Figure 18. Product Picture of Other
    Figure 19. Global Alzheimer's Disease Diagnostic Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 20. Global Alzheimer's Disease Diagnostic Sales Value Market Share by Application, 2023 & 2030
    Figure 21. North America Alzheimer's Disease Diagnostic Sales Value (2019-2030) & (US$ Million)
    Figure 22. North America Alzheimer's Disease Diagnostic Sales Value by Country (%), 2023 VS 2030
    Figure 23. Europe Alzheimer's Disease Diagnostic Sales Value (2019-2030) & (US$ Million)
    Figure 24. Europe Alzheimer's Disease Diagnostic Sales Value by Country (%), 2023 VS 2030
    Figure 25. Asia Pacific Alzheimer's Disease Diagnostic Sales Value (2019-2030) & (US$ Million)
    Figure 26. Asia Pacific Alzheimer's Disease Diagnostic Sales Value by Country (%), 2023 VS 2030
    Figure 27. South America Alzheimer's Disease Diagnostic Sales Value (2019-2030) & (US$ Million)
    Figure 28. South America Alzheimer's Disease Diagnostic Sales Value by Country (%), 2023 VS 2030
    Figure 29. Middle East & Africa Alzheimer's Disease Diagnostic Sales Value (2019-2030) & (US$ Million)
    Figure 30. Middle East & Africa Alzheimer's Disease Diagnostic Sales Value by Country (%), 2023 VS 2030
    Figure 31. Key Countries/Regions Alzheimer's Disease Diagnostic Sales Value (%), (2019-2030)
    Figure 32. United States Alzheimer's Disease Diagnostic Sales Value, (2019-2030) & (US$ Million)
    Figure 33. United States Alzheimer's Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
    Figure 34. United States Alzheimer's Disease Diagnostic Sales Value by Application (%), 2023 VS 2030
    Figure 35. Europe Alzheimer's Disease Diagnostic Sales Value, (2019-2030) & (US$ Million)
    Figure 36. Europe Alzheimer's Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
    Figure 37. Europe Alzheimer's Disease Diagnostic Sales Value by Application (%), 2023 VS 2030
    Figure 38. China Alzheimer's Disease Diagnostic Sales Value, (2019-2030) & (US$ Million)
    Figure 39. China Alzheimer's Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
    Figure 40. China Alzheimer's Disease Diagnostic Sales Value by Application (%), 2023 VS 2030
    Figure 41. Japan Alzheimer's Disease Diagnostic Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Japan Alzheimer's Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
    Figure 43. Japan Alzheimer's Disease Diagnostic Sales Value by Application (%), 2023 VS 2030
    Figure 44. South Korea Alzheimer's Disease Diagnostic Sales Value, (2019-2030) & (US$ Million)
    Figure 45. South Korea Alzheimer's Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
    Figure 46. South Korea Alzheimer's Disease Diagnostic Sales Value by Application (%), 2023 VS 2030
    Figure 47. Southeast Asia Alzheimer's Disease Diagnostic Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Alzheimer's Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
    Figure 49. Southeast Asia Alzheimer's Disease Diagnostic Sales Value by Application (%), 2023 VS 2030
    Figure 50. India Alzheimer's Disease Diagnostic Sales Value, (2019-2030) & (US$ Million)
    Figure 51. India Alzheimer's Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
    Figure 52. India Alzheimer's Disease Diagnostic Sales Value by Application (%), 2023 VS 2030
    Figure 53. Alzheimer's Disease Diagnostic Industrial Chain
    Figure 54. Alzheimer's Disease Diagnostic Manufacturing Cost Structure
    Figure 55. Channels of Distribution (Direct Sales, and Distribution)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

The global market for Alzheimer's Disease Diagnostic was estimated to be worth US$ 3618 million in 2023 and is forecast to a readjusted size of US$ 4024.3 million by 2030 with a CAGR of 1.5% during the forecast period 2024-2030

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Diagnostic, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Alzheimer's Disease Diagnostic by region & country, by Type, and by Application.

The Alzheimer's Disease Diagnostic market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Diagnostic.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Alzheimer's Disease Diagnostic manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Alzheimer's Disease Diagnostic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Alzheimer's Disease Diagnostic in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.